Compare FOSL & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOSL | ALEC |
|---|---|---|
| Founded | 1984 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 135.9M | 133.2M |
| IPO Year | 1993 | 2019 |
| Metric | FOSL | ALEC |
|---|---|---|
| Price | $3.88 | $1.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 8 |
| Target Price | ★ $5.00 | $3.50 |
| AVG Volume (30 Days) | 1.2M | ★ 1.7M |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,066,179,000.00 | $69,048,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $160.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.26 |
| 52 Week Low | $0.86 | $0.87 |
| 52 Week High | $4.40 | $3.40 |
| Indicator | FOSL | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 71.42 | 54.67 |
| Support Level | $3.61 | $1.18 |
| Resistance Level | $4.11 | $1.39 |
| Average True Range (ATR) | 0.28 | 0.10 |
| MACD | 0.09 | 0.07 |
| Stochastic Oscillator | 86.44 | 91.11 |
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.